SIR,-I was interested to read both the paper by Dr. C. Neubauer (27 June, p. 759) and also your leading article on the subject of serum folate and B12 levels and epilepsy (p. 744).
I have been involved in two recent research projects on this subject.' 2 I rather envy Dr. Neubauer's finding of therapeutic benefit from the administration of both folic acid and vitamin B12 to his patients. It was in the hope of arriving at just such a conclusion that we undertook the second piece of research mentioned above. Knowing full well the fallacies of personal assessments of behaviour improvement when undertaking a therapeutic programme, the efficacy of which one wishes to see established, we took the precaution of carrying out the drug trial under double-blind conditions, and also had a definite system of assessing behaviour. Dr. Neubauer appears to have overlooked these precautions, and perhaps therein lies the difference between his positive findings of therapeutic benefit, and our own less happy negative findings.
However, there is another important factor in that Dr. Neubauer administered both folic acid and vitamin B12, whereas we confined ourselves to giving only the former; it may well be that the combined administration does confer some superiority, and certainly the analogy of precipitation of subacute combined degeneration of the spinal cord when folic acid alone is given to some patients with megaloblastic anaemia is interesting. However, I think more rigorous proof is required before allowing the conclusion to pass unchallenged.
In Cancer and the Pill SIR,-I have seen over the last two years four cases of breast carcinoma where the disease seems to have started soon after the patient was launched on the contraceptive pill.
Many women are taking the pill for the first time at an age when the incidence of breast carcinoma starts to rise steeply. Much has been written about the thromboembolic risks, and the appropriate modifications in hormone dosage have been advised and largely heeded. But may it not be that the carcinoma risk is much more important? Our ignorance of the possible links between hormone imbalance and breast and uterine carcinoma is virtually complete. It is likely that there is a profound relationship in susceptible cases, and hints about this are only now coming
